Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates

被引:41
作者
Castner, SA [1 ]
Goldman-Rakic, PS [1 ]
机构
[1] Yale Univ, Sch Med, Neurobiol Sect, Dept Neurobiol, New Haven, CT 06510 USA
关键词
prefrontal lesion; behavioral sensitization; monkey; schizophrenia; hallucination; positive symptoms;
D O I
10.1016/S0006-3223(03)00292-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Repeated amphetamine (AMPH) exposure in nonhuman primates produces a chronic state of monoamine dysregulation and long-lasting changes in behaviors elicited by acute AMPH (including tracking, grasping "at thin air," manipulating nonapparent stimuli, and hypervigilance) in a manner that bears a marked resemblance to symptoms of both amphetamine psychosis and paranoid schizophrenia. These abnormal responses have historically been referred to as psychotomimetic or hallucinatory-like. In contrast to negative symptoms and cognitive deficits, the positive symptoms of schizophrenia including hallucinations have not traditionally been linked to prefrontal dysfunction. Methods: The dorsomedial (9/8B), dorsolateral (46/8A), and inferior (45/12) sectors of prefrontal cortex were lesioned, singly or in combination. Lesioned and non-lesioned control monkeys were sensitized over a 6-week period using an intermittent schedule of escalating low doses of AMPH. Behavioral responses to acute AMPH after chronic exposure were compared with preexposure responses. Results: Bilateral lesions of prefrontal cortex performed before subchronic AMPH suppressed the sensitization of hallucinatory-like behaviors but markedly enhanced locomotor sensitization compared with control animals. Conclusions: These findings indicate that the primate prefrontal cortex may be a substrate for the development of the full complement of behaviors elicited by AMPH sensitization, including hallucinatory-like behaviors. (C) 2003 Society of Biological Psychiatry.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 45 条
[1]  
BUCHANAN RW, 1990, AM J PSYCHIAT, V147, P290
[2]  
CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578
[3]  
Castner S. A., 1999, Society for Neuroscience Abstracts, V25, P1563
[4]  
Castner SA, 2001, BIOL PSYCHIAT, V49, p124S
[5]   Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys [J].
Castner, SA ;
Goldman-Rakic, PS .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (01) :10-28
[6]   Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine [J].
Castner, SA ;
Al-Tikriti, MS ;
Baldwin, RM ;
Seibyl, JP ;
Innis, RB ;
Goldman-Rakic, PS .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (01) :4-13
[7]   ANATOMICAL ANALYSIS OF THE INVOLVEMENT OF MESOLIMBOCORTICAL DOPAMINE IN THE LOCOMOTOR STIMULANT ACTIONS OF D-AMPHETAMINE AND APOMORPHINE [J].
CLARKE, PBS ;
JAKUBOVIC, A ;
FIBIGER, HC .
PSYCHOPHARMACOLOGY, 1988, 96 (04) :511-520
[8]   THE 2-SYNDROME CONCEPT - ORIGINS AND CURRENT STATUS [J].
CROW, TJ .
SCHIZOPHRENIA BULLETIN, 1985, 11 (03) :471-486
[9]   EVOLVING BEHAVIOR IN CLINICAL AND EXPERIMENTAL AMPHETAMINE (MODEL) PSYCHOSIS [J].
ELLINWOOD, EH ;
SUDILOVSKY, A ;
NELSON, LM .
AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (10) :1088-1093
[10]   AMPHETAMINE PSYCHOSIS .I. DESCRIPTION OF INDIVIDUALS AND PROCESS [J].
ELLINWOOD, EH .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1967, 144 (04) :273-+